Company Filing History:
3 out of 15,484 
1 out of 917 
Years Active: 2001-2013
Title: Innovations in Cytogenetics: The Contributions of Douglas Tkachuk
Introduction
Douglas Tkachuk is a notable inventor based in Livermore, CA (US), recognized for his significant contributions to the field of cytogenetics. With a total of 3 patents, Tkachuk has developed innovative methods and compositions that enhance the detection of genetic abnormalities. His work has implications for cancer research and diagnostics, particularly in identifying genetic rearrangements associated with diseases.
Latest Patents
Tkachuk's latest patents include a method for detecting genetic deletions associated with chromosomal abnormalities. This patent outlines methods and compositions for staining based on nucleic acid sequences that utilize nucleic acid probes. These methods produce staining patterns tailored for specific cytogenetic analyses, allowing for reliable signals in both interphase and metaphase chromosomal material. The nucleic acid probes used are typically of a complexity greater than 50 kb, depending on the cytogenetic application. Additionally, Tkachuk has developed methods and reagents for detecting genetic rearrangements, particularly useful in tumor cytogenetics and the detection of disease-related loci, such as chronic myelogenous leukemia (CML).
Career Highlights
Throughout his career, Tkachuk has worked with prestigious institutions, including the University of California and The University of Chicago. His research has focused on developing advanced techniques for cytogenetic research, which are essential for differentiating genetically similar diseases and for various prognostic and diagnostic applications.
Collaborations
Some of Tkachuk's notable collaborators include Joe W. Gray and Daniel Pinkel, who have contributed to the advancement of cytogenetic methodologies alongside him.
Conclusion
Douglas Tkachuk's innovative work in cytogenetics has paved the way for improved diagnostic techniques in cancer research. His patents reflect a commitment to enhancing the understanding of genetic abnormalities, ultimately benefiting the medical community and patients alike.